Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Olga F. Kuznetsova"'
Autor:
Daria D. Vaulina, Kira I. Stosman, Konstantin V. Sivak, Andrey G. Aleksandrov, Nikolai B. Viktorov, Nikolay N. Kuzmich, Mariia M. Kiseleva, Olga F. Kuznetsova, Natalia A. Gomzina
Publikováno v:
Molecules, Vol 26, Iss 21, p 6630 (2021)
Neolignans honokiol and 4′-O-methylhonokiol (MH) and their derivatives have pronounced anti-inflammatory activity, as evidenced by numerous pharmacological studies. Literature data suggested that cyclooxygenase type 2 (COX-2) may be a target for th
Externí odkaz:
https://doaj.org/article/dc280d6893ef40ce9b8093ad7de45e15
Autor:
Viktoriya V. Orlovskaya, Austin S. Craig, Olga S. Fedorova, Olga F. Kuznetsova, Bernd Neumaier, Raisa N. Krasikova, Boris D. Zlatopolskiy
Publikováno v:
Molecules, Vol 26, Iss 18, p 5550 (2021)
6-l-[18F]Fluoro-m-tyrosine (6-l-[18F]FMT) represents a valuable alternative to 6-l-[18F]FDOPA which is conventionally used for the diagnosis and staging of Parkinson’s disease. However, clinical applications of 6-l-[18F]FMT have been limited by the
Externí odkaz:
https://doaj.org/article/5752d86ea0fa4051a4a8486c56970e7d
Autor:
Victoriya V. Orlovskaya, Daniel J. Modemann, Olga F. Kuznetsova, Olga S. Fedorova, Elizaveta A. Urusova, Niklas Kolks, Bernd Neumaier, Raisa N. Krasikova, Boris D. Zlatopolskiy
Publikováno v:
Molecules, Vol 24, Iss 17, p 3197 (2019)
In the era of personalized precision medicine, positron emission tomography (PET) and related hybrid methods like PET/CT and PET/MRI gain recognition as indispensable tools of clinical diagnostics. A broader implementation of these imaging modalities
Externí odkaz:
https://doaj.org/article/5f02101a24e341ad8eed518de0917a0a
Autor:
Linjing Mu, Adrienne Müller, Cristina Müller, Tobias L. Ross, Roger Schibli, Dominic Franck, Christian Schweinsberg, Olga F. Kuznetsova, Stefanie D. Krämer, Claudia Keller, Simon M. Ametamey
Publikováno v:
Journal of nuclear medicine : official publication Society of Nuclear Medicine
UNLABELLED Large neutral l amino acids are substrates of system L amino acid transporters. The level of one of these LAT1 is increased in many tumors. Aromatic l amino acids may also be substrates of aromatic l amino acid decarboxylase (AADC) the lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d8e69978b7decc8bd9734f7a8e9371
https://www.zora.uzh.ch/id/eprint/71392/
https://www.zora.uzh.ch/id/eprint/71392/
Autor:
Raisa N. Krasikova, Olga F. Kuznetsova, Olga S. Fedorova, Yuri N. Belokon, Viktor I. Maleev, Linjing Mu, Simon Ametamey, P. August Schubiger, Matthias Friebe, Mathias Berndt, Norman Koglin, Andre Mueller, Keith Graham, Lutz Lehmann, Ludger M. Dinkelborg
Publikováno v:
Journal of Medicinal Chemistry; Jan2011, Vol. 54 Issue 1, p406-410, 5p